|
Carmen Sanges
EU Initiatives - Cellular Immunotherapy program - scientific project lead
University Hospital Würzburg
Würzburg
Germany
|
"I'm Dr. Carmen Sanges, holding a PhD in Medical Biotechnology and currently serving as the EU Initiatives Scientific Project Lead for the Cellular Immunotherapy Program at the University Clinic Würzburg. My expertise lies in coordinating and advising various initiatives funded by the European Commission under the Horizon 2020 framework, notably the T2EVOLVE project. I specialize in developing synergistic approaches across EU consortia in cell and gene therapy, aiming to accelerate achievements and leverage potential.
As one of the coordinators, I oversee the European #T2EVOLVE consortium, supporting strategic decisions, bridging synergies, and fostering clear communication among partners. I'm deeply involved in stakeholder community building, leading focused discussions, and shaping the vision and mission of T2EVOLVE.
Additionally, I play a pivotal role in the #AIDPATH consortium, spearheading clinical readiness, regulatory strategies, and stakeholder engagement for the innovative AI-driven ATMP manufacturing platform. I'm proud to contribute my expertise as a member of the Regulatory Board in the ImSAVAR EU project and the EUCCAT working group at EUHA.
I'm also a partner in the #JOIN4ATMP European initiative and the recently funded EU project #CERTAINTY, where I serve as a connector member, facilitating synergies between programs. Moreover, I take pride in my role as a member of the Advisory Board of the #ASCERTAIN project.
In addition to my current roles, I bring 7 years of experience in clinical operation management within the industry. This experience has honed my skills in navigating the complexities of clinical trials, operational logistics, and regulatory compliance, ensuring the successful execution and management of clinical operations.
My professional journey includes a robust background in medical biotechnology research and development, where I've contributed to numerous publications and presented at various international conferences. My academic pursuits have always been aligned with my passion for translational medicine, bridging the gap between laboratory research and clinical application."
As one of the coordinators, I oversee the European #T2EVOLVE consortium, supporting strategic decisions, bridging synergies, and fostering clear communication among partners. I'm deeply involved in stakeholder community building, leading focused discussions, and shaping the vision and mission of T2EVOLVE.
Additionally, I play a pivotal role in the #AIDPATH consortium, spearheading clinical readiness, regulatory strategies, and stakeholder engagement for the innovative AI-driven ATMP manufacturing platform. I'm proud to contribute my expertise as a member of the Regulatory Board in the ImSAVAR EU project and the EUCCAT working group at EUHA.
I'm also a partner in the #JOIN4ATMP European initiative and the recently funded EU project #CERTAINTY, where I serve as a connector member, facilitating synergies between programs. Moreover, I take pride in my role as a member of the Advisory Board of the #ASCERTAIN project.
In addition to my current roles, I bring 7 years of experience in clinical operation management within the industry. This experience has honed my skills in navigating the complexities of clinical trials, operational logistics, and regulatory compliance, ensuring the successful execution and management of clinical operations.
My professional journey includes a robust background in medical biotechnology research and development, where I've contributed to numerous publications and presented at various international conferences. My academic pursuits have always been aligned with my passion for translational medicine, bridging the gap between laboratory research and clinical application."